News Updates
More Articles
- The Pitfalls and Promise of Cell and Gene Therapy Development: A Time for Concerted Action
- “Not Just Checking a Box”: A Call to Rethink Patient Involvement in the EU
- From Cells to Animals and Back Again: The Shifting Landscape of Cancer Efficacy and Safety Models
- Addressing Inequity: Embedding Inclusion and Diversity in UK Clinical Trials
- The Next AI Revolution: Computer System Validation
Shaping Future-Oriented R&D Talent Innovation in China: Part 2: Education Reforms and Capability Enhancements
The first part of this two-part article overviewed general challenges that pharmaceutical companies face in developing innovative R&D talent from a global perspective. This part focuses on these challenges and possible solutions to developing innovative pharmaceutical and biotechnology R&D talent in China.